Multi-omics Exploration of Triple Negative Breast Cancer for ADC, Bispecifics and Antibody Drug Development
Thu, Nov 14
|Webinar
Time & Location
Nov 14, 2024, 8:00 AM – 9:00 AM PST
Webinar
About the event
How to leverage multi-omics data to drive innovations in antibody-drug conjugates (ADC), bispecifics, and antibody drug development, particularly for Triple Negative Breast Cancer (TNBC)?
Join us for this webinar to discuss further on this topic with Dr, Brett Pickett (Assistant Professor @ Brigham Young University) and Jenny Pham (Head of Training Programs @ Pythia Biosciences).
In this webinar, you will learn:
- Comparison of methods to determine immune cell signatures in bulk RNA, and their mechanistic contribution to Triple-Negative Breast Cancer
- Combining insights from multi-omics TNBC data to identify potential targets for ADC and bispecifics using C-DIAM Multi-Omics Studio
Date and time: 8AM PST | 11AM EST Thursday November 14, 2024